“There’s a lot of people in the business that are into the ‘buzzword and conference’ side of the business,” Arch cofounder
This is a philosophy Burow echoes when she discusses what should come next in thinking about biotechnology investment. “You’ll make money if the science is there and you’re making an impact on patients’ lives.” Vir Biotechnology, which was founded by Nelsen in 2016 to develop new treatments and vaccines against infectious diseases such as HPV, influenza, tuberculosis and AIDS. The company, which had its IPO in October 2019, now has its sights on COVID-19. It’s currently working with a number of partners on potentialGeneration Bio, a Cambridge, Massachusetts-based gene therapy startup.
A big winner in this regard will be telemedicine providers. Social distancing will make it more normal to consult with medical professionals through the internet. This will especially be true for“There’s a lot of amazing things that can happen over Zoom, or email and active texting dialogues,” she says.
WomenBeh refreshing read
abhimanyusrana
Health Health Latest News, Health Health Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: Mirror Celeb - 🏆 476. / 51 Read more »
Source: HealthyWomen - 🏆 29. / 68 Read more »
Source: cnnbrk - 🏆 393. / 55 Read more »